Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial

Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now includes a Locations section listing Texas as a study site (Houston, TX); the HHS Vulnerability Disclosure link and the Texas Locations header were removed.
    Difference
    0.2%
    Check dated 2025-12-18T03:08:18.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    24 days ago
    No Change Detected
  6. Check
    38 days ago
    Change Detected
    Summary
    The Publications section now notes that PubMed auto-fills publications and may not be about the study, and the revision is updated to v3.3.2; the prior PubMed disclaimer and v3.2.0 revision were removed.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:03.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The government funding status notice has been removed from the page. This change does not affect study details, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:18:20.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    No significant changes to the Study Details page were observed. Any differences appear to be minor formatting or metadata updates that do not affect the study information.
    Difference
    0.3%
    Check dated 2025-11-03T21:19:29.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    Upgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T05:49:59.000Z thumbnail image
  10. Check
    96 days ago
    Change Detected
    Summary
    The page shifts its focus to a broader Ovarian Cancer topic with a new v3.1.0 revision, while removing older, more granular histologic terms and a v3.0.2 tag. This indicates an updated, streamlined content branding rather than adding new substantive details.
    Difference
    0.9%
    Check dated 2025-09-29T03:10:40.000Z thumbnail image

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.